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 The oxidative features of GBM are in line with the needed requirements for the ferroptosis induction.
 GBM cells modify their ferroptotic protein profile, establishing a defense mechanism in order to avoid
spontaneous ferroptosis. This evidence confirms the importance of this non-apoptotic mechanism in GBM.
 Dual therapies are in the spotlight as they enhance anticancer effects, rather than delivering solely FINs.
 Future research at GBM should focus on precise operation of the ferroptotic pathways and on the dual
therapies, in order to finally find the golden standard treatment for GBM.
Ferroptosis in GBM cells
Ferroptosis Inducing Compounds
OBJECTIVES
→ To determine the main oxidative features of GBM cells and ferroptosis.
→ To understand ferroptosis regulation in GBM cells.
→ To establish the main ferroptosis inducing compounds (FINs) that have
been tested on GBM cell lines or murine xenografts.
Glioblastoma multiforme (GBM) is one of the most common and aggressive primary brain tumors.
Despite the available therapies, life expectancy for patients is very poor, with a survival rate of around
14.6 months. Therefore, a definitive therapeutic strategy for GBM is urgently needed. This is where
ferroptosis comes in, a new type of programmed non-apoptotic, iron-dependent cell death recently
discovered. The oxidative features of brain tissue and glioblastomas make this neoplasm susceptible
to the induction of ferroptosis.
Extensive bibliographic search in Pubmed and Web of
Science, according to the keywords listed on the right.
Article inclusion criteria:
 Original articles, most relevant reviews, relation
with the reviewed topic, publication date (> 2012)
Lipid peroxidation is the triggering event of
ferroptosis as it induces destabilization of
the cell membrane. Lipid peroxidation is the
result of:
Ferroptosis is directly related to:
Figure 2. Ferroptosis triggering events. A| Lipid peroxides
formation by means of B| Labile Iron Pool and C| ROS production.
GBM cells balance their sensitivity to the induction of ferroptosis by upregulating or downregulating the proteins
involved in this cell death. Thus, they exhibit a distinctive ferroptotic protein profile that protects them from
spontaneous ferroptosis.
• High oxygen consumption
• Elevated ROS concentration
• Increased iron uptake
• Enhanced lipid metabolism
• Less antioxidant activity
It is the consequence of an imbalance
between the production of free radicals and
the antioxidant systems.
• Reactive oxygen species (ROS) are
produced as a result of incomplete oxygen
reduction, and its high concentration can
induce lipid damage.
Despite the v ilable therapies, life xpectancy for patients is very poor, with a survival rate of
around 14.6 months. Therefore, a definitiv therapeutic strategy for GBM is urgently needed. T is is
where ferr pto is comes in, a new type of programmed n n-apoptotic, iron-dep ndent cell death
recently discovered. The oxidative features of brain tissue and glioblastomas make this neo lasm
susceptible to the induc ion of ferroptosis.
around 14.6 months. Ther fore, a definitive therapeutic strategy for GBM is urg ntly needed. It ha
This i this neoplasm susceptibl to the inductio f ferroptosis.
Labile Iron Pool is the main source of Fe2+ to
be considered in lipid peroxidation, and
mainly derives from transferrin (extracellular
uptake) or from ferritinophagy (ferritin
degradation).
• Released Fe2+ will be able to react with
membrane phospholipids by the Fenton
reaction.
RESULTS
Further studies show more powerful effects when FINs are combined with pre-existing therapies for GBM:
recently bec me apparent that the ox dative featur s f GBM make this neoplasm susceptible to
the induction of ferropt sis, a newly type f programmed n n-ap ptotic cell de th.
Dual therapy
 Still, they pose some challenges when used by themselves.
Figure 5. The three types of cell death that are induced when combining
ferroptosis inducing compounds with temozolomide (chemotherapeutic agent)
and/or radiation.
Figure 1.Main oxidative features of GBM.
• Temozolomide: alkylating agent that
induces cell death by apoptosis and
autophagy.
• Radiation: kills cancer cells by
inducing cell cycle arrest and
apoptosis.
Anticancer therapy is reinforced, as
multiple types of cell death are
triggered. There is a better chance of
eliminating the resistant clones.
Figure 4. FINs tested in human
GBM cells and classified by
their main function.
Diagram on the right represents the imbalance that must be
induced in order for the GBM cells to undergo ferroptosis.
The blue forces must exceed the green forces.
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Ferroptosis can be induced in GBM cells upon the administration of FINs. These substances can act
through multiple mechanisms, all of them involving an increase in oxidative stress and iron
accumulation, resulting in lipid peroxidation. Here those FINs tested in human GBM cells with
significant results are presented, although some appear to be more potent than others.
o a
System Xc-:
Cystine-glutamate antiporter directly
related to GSH formation.
Glutathione Peroxidase 4 (GPx4):
Antioxidant enzyme responsible for
reducing membrane lipid peroxides.
Long-chain acyl-CoA synthetase 4 
(ACSL4):
Forms long-chain fatty acyl-CoAs
needed for lipid peroxidation.
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Figure 3. The upregulated (green) and downregulated (blue) ferroptotic proteins in GBM cells are
shown. The final effect is ferroptosis inhibition.
